News Story: Full Text
Sponsored By
Gleolan for brain tumors
Please Click On The Above Banner For More Details
Braintumor Website

Northwest rejects reports of green light for brain cancer vaccine

Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)


Posted on: 07/16/2007

Northwest rejects reports of green light for brain cancer vaccine

LONDON, Jul. 16, 2007 (AFX International Focus) -- Northwest Biotherapeutics Inc (OTCBB:NWBO) refuted 'certain media reports' which claimed that it has received a market authorization for its therapeutic brain cancer vaccine from the Swiss authorities.

However, the company plans to apply for marketing authorization for the vaccine by the end of this year, adding the process of this fulfilment is under way.

The authorization will allow the company to export patients' immune cells and tumour tissue for vaccine manufacturing in the US, and import the patients' brain finished vaccine into Switzerland, the company added.

The company has also rejected media reports which 'erroneously' stated that its shareholders Toucan Capital and/or Toucan Partners have sold shares at the time of financing, adding such reports are incorrect.

Copyright AFX News Limited 2007. All rights reserved.

The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.

Newstex ID: AFX-0013-18154807


 Top of page

Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557